Answers are grounded in this paper and cite their sources.
Ifosfamide is a relatively new cytotoxic drug with activity against many tumours including oat-cell lung cancer (Haggard, 1967), ovarian cancer (De La Garza & Cardenas, 1982), testicular tumours (Schmoll, 1982), osteosarcoma (Marti et al, 1981), soft-tissue sarcoma (Czownicki & Utracka, 1982; Stuart-Harris et al, 1983) and Hodgkin's lymphoma (Czownicki & Utracka-Hutka, 1977). Because of its activity in soft-tissue sarcoma we have used it in combination with radiotherapy as primary treatment for this condition. We report a case in which the combination of ifosfamide and radiation led to an enhanced radiation reaction.
No takes yet. Share an insight, caveat, or question.
J. J. Nicoll (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: